Monoclonal Antibodies Over Time: What’s Changed?

Monoclonal Antibodies

Monoclonal antibodies (or mAbs) are special proteins made by identical immune cells that all come from the same original cell. These proteins are designed to recognize and attach to specific targets, like viruses, bacteria, or cancer cells. Since 2014, the FDA has approved at least five new monoclonal antibody treatments every year, and that number […]

Clinilabs Expands Executive Leadership Team With Key Appointments

Clinilabs, LLC, a leading full-service contract research organization (CRO) specializing in central nervous system (CNS) drug and medical technology development, today announced the appointments of David Hagerman as Chief Financial Officer (CFO) and Jeanine Falinski as Senior Vice President of Commercial Development. These strategic additions to the executive team underscore Clinilabs’ commitment to strengthening its […]